Analgesics are among the most commonly prescribed drugs in the world and yet, finding novel targets and mechanisms that may elevate hard to treat pain is becoming more difficult. After nearly 20 years of successful
Pain Therapeutics conferences, join us for the 18th Annual
Pain Therapeutics conference in May to explore novel targets for pain therapeutics, new translational approaches and pipeline drug development from the leading pharma companies in pain management.
With more case studies, improved networking opportunities and presentations on exciting cutting edge research, the 18th Annual
Pain Therapeutics conference will equip you with the latest knowledge to advance your research and trials.
Benefits of Attending
- Discover the novel targets for pain management and hear how leading pharma companies are utilising them to elevate pain across a range of pain types.
- Learn from exciting case studies of analgesic drug development and trials.
- Explore the mechanisms by which that latest drugs elevate pain.
- Discuss the future of pain therapeutics and how big data and technology are shaping the industry..
- Advance your research and trials with the latest advice from the regulatory bodies
- Hear industry perspectives from leading pharamceutical companies
The upcoming
Pain Therapeutics conference moves away from well discussed topics such as opioid dependence and animal models and focuses on the most exciting current research, opinions, novel targets and mechanisms and advances in the field of analgesic medicine
Plus Two Interactive Half-Day Post-Conference Workshops | Wednesday 23rd May 2018
Workshop A:
How Should The Likely Future Pain Therapeutic Landscape Inform Current Drug Development?Workshop Leader: Joanne Taylor, Head of Neuroscience, Prescient Healthcare Group
08.30 - 12.30
Workshop B:
Clinical, Regulatory and Market Access Aspects in the Development of Medicinal Products intended for the Treatment of Pain in Europe and USAWorkshop Leader: Simon Ruini, Managing Director, Pharma Design Limited
13.30 - 17.30
Speakers
- Alexander Oksche, Executive Director , Mundipharma Research GmbH & Co. KG
- Daniel Mikol, Executive Medicl Director Global Development Neuroscience, Amgen
- Eric Nisenbaum, Head of Neurophysiology, Eli Lilly & Co
- Gordon Munro, Senior Scientist, Danish Headache Centre
- Iain Chessell, VP & Head, IMED Neuroscience , AstraZeneca
- Jean Deregnaucourt, Scientific Director, Innopain
- Jenny Laird, Senior Director, Search & Evaluation at Eli Lilly, Eli Lilly And Company
- Joseph Stauffer, Chief Medical Officer, Cara Therapeutics
- Kerrie Brady, Chief Business Officer, Executive VP Strategy, Centrexion Therapeutics Corp.
- Lisa Broad, Senior Research Advisor , Eli Lilly and Company
- Mark Field, SVP, Head Global Clinical Development , Grunenthal GmbH
- Mikhail Kalinichev, Director, in vivo Neurology, Ipsen
- Neil Singla, Founder & Chief Scientific Officer, Lotus Clinical Research, Llc
- Randall Stevens, Chief Medical Officer, Centrexion Therapeutics Corp.
- Simon Ruini, Director, phd pharma design
- Sigal Meilin, Chief Scientific Officer, MD Biosciences
- Stephen Doberstein, Senior Vice President, Research and Development and Chief R&D Officer, Nektar Therapeutics
- Theo Meert, Head of Global Government Grant Office, Janssen Pharmaceutical NV, J&J
- Toni Williamson, Senior Director Non-Clinical Research, Flexion Therapeutics
- Torsten Madsen, CMO, Aptinyx
- William Schmidt, Vice President, Clinical Development , Viromed
- Yanina Flossbach, Associate Medical Director Neuroscience , Novartis Pharmaceuticals
Please fill in your name and email to receive the conference agenda of this event.
The agenda is available as PDF under downloads at the right side of the page.
Venue
Holiday Inn Kensington Forum
97 Cromwell Rd, Kensington, SW7 4DN
London, UK
Who Should attend
Chief Executive Officer, Chief Scientific Officers, Chief Medical Officers, Managing Directors, CEO, Head of Department, Principal Research Scientists, Clinical lead, Clinical Operations in the following fields:
- Pain and Migraine
- Inflammation
- Chronic Pain
- Neuropathic Pain
- Analgesic pre-clinical development
- Anaesthesia and Pain Management
- CNS clinical trials
- Ion Channel Pharmacology
- Pharmacology Intelligence
- Translational science
- Drug development
- Exploratory development
Venue
Holiday Inn Kensington Forum97 Cromwell Road
London, United Kingdom
